Live from the NIH registry
Studies recruiting near Elk Grove right now
Top 25 of 629 recruiting studies, sorted by proximity — each links to its official registry page
A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)
B Acute Lymphoblastic Leukemia
Phase 2
Interventional 222 participants sought
University of California Davis Comprehensive Cancer Center — Sacramento, California (12.9 mi)
· Sponsor: National Cancer Institute (NCI)
Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer
PIK3CA Mutation, HER2- Negative Breast Cancer
Phase 3
Interventional 540 participants sought
University of California, Davis Comprehensive Cancer Center — Sacramento, California (12.9 mi)
· Sponsor: Relay Therapeutics, Inc.
A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
Carcinoma, Transitional Cell, Urinary Bladder Neoplasms
Phase 3
Interventional 450 participants sought
University of California Davis (UC Davis) Comprehensive Cancer Center — Sacramento, California (12.9 mi)
· Sponsor: Eli Lilly and Company
GATEWAY: Safety Evaluation of the MiniMed™ NMX8-AID System in Children and Adults Living With Diabetes
Type 1 Diabetes Mellitus, Type 2 Diabetes Mellitus
N/A
Interventional 400 participants sought
Sutter Institute for Medical Research — Sacramento, California (12.9 mi)
· Sponsor: Medtronic MiniMed, Inc.
A Study in People With Diabetic Macular Edema to Test How Well Different Doses of BI 3812465 Are Tolerated
Diabetic Macular Edema
Phase 1, Phase 2
Interventional 49 participants sought
Retinal Consultants Medical Group — Sacramento, California (12.9 mi)
· Sponsor: Boehringer Ingelheim
Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer
Previously Treated Non-Small Cell Lung Cancer
Phase 2, Phase 3
Interventional 10,000 participants sought
Mercy Cancer Center - Elk Grove — Elk Grove, California (0.8 mi)
· Sponsor: SWOG Cancer Research Network
Lenalidomide, and Dexamethasone With or Without Daratumumab in Treating Patients With High-Risk Smoldering Myeloma
Smoldering Plasma Cell Myeloma
Phase 3
Interventional 288 participants sought
Mercy Cancer Center - Elk Grove — Elk Grove, California (0.8 mi)
· Sponsor: ECOG-ACRIN Cancer Research Group
A Study to Determine the Efficacy and Safety of Finerenone and SGLT2i in Combination in Hospitalized Patients With Heart Failure (CONFIRMATION-HF)
Heart Failure
Phase 3
Interventional 1,500 participants sought
CON-10024 Sacramento, CA Investigational Site — Sacramento, California (12.9 mi)
· Sponsor: Colorado Prevention Center
Treatment of Moderate to Severe Refractory Crohn's Disease
Crohns Disease
Phase 1, Phase 2
Interventional 39 participants sought
University of California, Davis — Sacramento, California (12.9 mi)
· Sponsor: Tr1X, Inc.
ACX-362E [Ibezapolstat] for Oral Treatment of Recurrent Clostridioides Difficile Infection
Clostridium Difficile Infection Recurrence
Phase 2
Interventional 20 participants sought
UC Davis Medical Center — Sacramento, California (12.9 mi)
· Sponsor: Acurx Pharmaceuticals Inc.
Phase 1 Study of C.001 in Retinal Degeneration
Geographic Atrophy, Stargardt Disease
Phase 1
Interventional 15 participants sought
Retinal Consultants Medical Group — Sacramento, California (12.9 mi)
· Sponsor: Cellio Therapeutics Inc
CAR-T Cells for HIV Infection
HIV Infections
Phase 1, Phase 2
Interventional 18 participants sought
University of California, Davis — Sacramento, California (12.9 mi)
· Sponsor: Steven Deeks
A Study Assessing Corneal Endothelial Cells in Participants With Neovascular Age-related Macular Degeneration (nAMD) Treated With the Port Delivery System With Ranibizumab (PDS)
Neovascular Age-related Macular Degeneration
Phase 4
Interventional 188 participants sought
Retinal Consultants Med Group — Sacramento, California (12.9 mi)
· Sponsor: Genentech, Inc.
Testing Higher Dose Radiation Therapy for Locally Advanced Pancreatic Cancer
Locally Advanced Unresectable Pancreatic Ductal Adenocarcinoma, Stage II Pancreatic Cancer AJCC v8
Phase 3
Interventional 356 participants sought
Sutter Medical Center Sacramento — Sacramento, California (12.9 mi)
· Sponsor: NRG Oncology
LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis
Ulcerative Colitis (UC), Ulcerative Colitis, Active Moderate
Phase 2
Interventional 1,431 participants sought
GMC Clinical Research — Folsom, California (21.3 mi)
· Sponsor: Eli Lilly and Company
Pilot Study Exploring the Effects of Rhythmic Auditory Stimulation on Gait in People With Motor Incomplete Spinal Cord Injury
Spinal Cord Injury
N/A
Interventional 15 participants sought
UC Davis Point West — Sacramento, California (12.9 mi)
· Sponsor: University of California, Davis
TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
Lymphoma, Non-Hodgkin, Multiple Myeloma
Phase 2
Interventional 4,200 participants sought
Kaiser Permanente - Sacramento Medical Center — Sacramento, California (12.9 mi)
· Sponsor: American Society of Clinical Oncology
Outcomes of Running Locking Suture vs Standard Running Suture in Surgical Wounds
Scarring
N/A
Interventional 50 participants sought
University of California, Davis - Dermatology Department — Sacramento, California (12.9 mi)
· Sponsor: University of California, Davis
E-Mindfulness Approaches for Living After Breast Cancer
Breast Cancer, Depression
Phase 3
Interventional 402 participants sought
Kaiser Permanente Downtown Commons — Sacramento, California (12.9 mi)
· Sponsor: NRG Oncology
A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer
Non-Small Cell Lung Cancer, KRAS G12C Lung Cancer
Phase 3
Interventional 600 participants sought
Sutter Institute for Medical Research — Roseville, California (23.8 mi)
· Sponsor: Hoffmann-La Roche
Phase 2/3 Trial of Izalontamab Brengitecan vs Platinum-based Chemotherapy for Metastatic Urothelial Cancer With Disease Progression on or After Immunotherapy
Urothelial Cancer
Phase 2, Phase 3
Interventional 470 participants sought
Sutter Health - Sutter Institute for Medical Research — Sacramento, California (12.9 mi)
· Sponsor: Bristol-Myers Squibb
Comparing Combinations of Drugs to Treat Newly Diagnosed Multiple Myeloma (NDMM) When a Stem Cell Transplant is Not a Medically Suitable Treatment
Plasma Cell Myeloma
Phase 3
Interventional 510 participants sought
Mercy Cancer Center - Elk Grove — Elk Grove, California (0.8 mi)
· Sponsor: SWOG Cancer Research Network
Decolonization to Reduce After-Surgery Events of Surgical Site Infection
Surgical Site Infection
Phase 4
Interventional 2,700 participants sought
University of California, Davis Medical Center — Sacramento, California (12.9 mi)
· Sponsor: University of California, Irvine
Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)
Triple-Negative Breast Cancer
Phase 3
Interventional 1,530 participants sought
Kaiser Permanente - Roseville ( Site 0081) — Roseville, California (23.8 mi)
· Sponsor: Merck Sharp & Dohme LLC
A Study to Investigate the Efficacy, Safety and Tolerability of Remibrutinib Versus Placebo in Adult Patients With Generalized Myasthenia Gravis
Generalized Myasthenia Gravis
Phase 3
Interventional 180 participants sought
California Pacific Medical Center — Sacramento, California (12.9 mi)
· Sponsor: Novartis Pharmaceuticals